Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor - PubMed (original) (raw)
Review
. 2018 Sep;238(3):R143-R159.
doi: 10.1530/JOE-18-0163. Epub 2018 Jun 6.
Affiliations
- PMID: 29875164
- DOI: 10.1530/JOE-18-0163
Review
Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
Clara Lefranc et al. J Endocrinol. 2018 Sep.
Abstract
Obesity is a multifaceted, chronic, low-grade inflammation disease characterized by excess accumulation of dysfunctional adipose tissue. It is often associated with the development of cardiovascular (CV) disorders, insulin resistance and diabetes. Under pathological conditions like in obesity, adipose tissue secretes bioactive molecules called 'adipokines', including cytokines, hormones and reactive oxygen species (ROS). There is evidence suggesting that oxidative stress, in particular, the ROS imbalance in adipose tissue, may be the mechanistic link between obesity and its associated CV and metabolic complications. Mitochondria in adipose tissue are an important source of ROS and their dysfunction contributes to the pathogenesis of obesity-related type 2 diabetes. Mitochondrial function is regulated by several factors in order to preserve mitochondria integrity and dynamics. Moreover, the renin-angiotensin-aldosterone system is over-activated in obesity. In this review, we focus on the pathophysiological role of the mineralocorticoid receptor in the adipose tissue and its contribution to obesity-associated metabolic and CV complications. More specifically, we discuss whether dysregulation of the mineralocorticoid system within the adipose tissue may be the upstream mechanism and one of the early events in the development of obesity, via induction of oxidative stress and mitochondrial dysfunction, thus impacting on systemic metabolism and the CV system.
Keywords: adipose tissue; mineralocorticoid receptor; mitochondrial dysfunction; obesity; oxidative stress.
© 2018 Society for Endocrinology.
Similar articles
- The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
Ramalingam L, Menikdiwela K, LeMieux M, Dufour JM, Kaur G, Kalupahana N, Moustaid-Moussa N. Ramalingam L, et al. Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1106-1114. doi: 10.1016/j.bbadis.2016.07.019. Epub 2016 Aug 4. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27497523 Review. - Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
Lastra G, Sowers JR. Lastra G, et al. Horm Mol Biol Clin Investig. 2013 Sep;15(2):49-57. doi: 10.1515/hmbci-2013-0025. Horm Mol Biol Clin Investig. 2013. PMID: 25436732 Review. - The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
Jia G, Aroor AR, Sowers JR. Jia G, et al. Cardiovasc Res. 2017 Jul 1;113(9):1055-1063. doi: 10.1093/cvr/cvx097. Cardiovasc Res. 2017. PMID: 28838041 Free PMC article. Review. - Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress.
Sindhu S, Akhter N, Kochumon S, Thomas R, Wilson A, Shenouda S, Tuomilehto J, Ahmad R. Sindhu S, et al. Cell Physiol Biochem. 2018;45(2):572-590. doi: 10.1159/000487034. Epub 2018 Jan 30. Cell Physiol Biochem. 2018. PMID: 29428931 - Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).
Even SE, Dulak-Lis MG, Touyz RM, Nguyen Dinh Cat A. Even SE, et al. Horm Mol Biol Clin Investig. 2014 Aug;19(2):89-101. doi: 10.1515/hmbci-2014-0013. Horm Mol Biol Clin Investig. 2014. PMID: 25390018 Review.
Cited by
- Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation.
Balan AI, Halațiu VB, Scridon A. Balan AI, et al. Antioxidants (Basel). 2024 Jan 17;13(1):117. doi: 10.3390/antiox13010117. Antioxidants (Basel). 2024. PMID: 38247541 Free PMC article. Review. - The associations of oxidative stress and inflammatory markers with obesity in Iranian population: MASHAD cohort study.
Ghazizadeh H, Mansoori A, Sahranavard T, Nasrabadi M, Hadiloo K, Andalibi NS, Azmon M, Tavallaei S, Timar A, Ferns GA, Ghayour-Mobarhan M. Ghazizadeh H, et al. BMC Endocr Disord. 2024 Apr 29;24(1):56. doi: 10.1186/s12902-024-01590-9. BMC Endocr Disord. 2024. PMID: 38685027 Free PMC article. - Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes.
Vezza T, Abad-Jiménez Z, Marti-Cabrera M, Rocha M, Víctor VM. Vezza T, et al. Antioxidants (Basel). 2020 Sep 10;9(9):848. doi: 10.3390/antiox9090848. Antioxidants (Basel). 2020. PMID: 32927712 Free PMC article. Review. - Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls.
Filippov MA, Tatarnikova OG, Pozdnyakova NV, Vorobyov VV. Filippov MA, et al. Neural Regen Res. 2021 Feb;16(2):223-233. doi: 10.4103/1673-5374.290878. Neural Regen Res. 2021. PMID: 32859768 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical